Gastroesophageal Reflux Disease Therapeutics Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 December 26
SKU : PH5060
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
What is the Projected CAGR value of the Gastroesophageal Reflux Disease Therapeutics Market ?
Gastroesophageal Reflux Disease Therapeutics Market is expected to grow at a CAGR of 4% during the forecast period 2023-2030.
Who are the key players in Gastroesophageal Reflux Disease Therapeutics Market ?
Major players are Merck Sharp & Dohme Pty Ltd., McNeil Consumer Pharmaceuticals Co., Amneal Pharmaceuticals LLC, AstraZeneca Pharmaceuticals LP, Teva Pharmaceuticals USA, Inc., Takeda Pharmaceuticals America, Inc., Eisai R&D Management Co., Ltd, TWi Pharmaceuticals USA, Inc., Lannett and Saol Therapeutics Inc.
Related Reports
pharmaceuticalsGastrointestinal Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 February 23
Starting from
$4350
pharmaceuticalsGastrointestinal Cancer Drugs Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 24
Starting from
$4350
medical-devicesGastrointestinal Stents Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 December 20
Starting from
$4350